Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update
about
Management of elderly and unfit patients with chronic lymphocytic leukemia.Idelalisib and bendamustine combination is synergistic and increases DNA damage response in chronic lymphocytic leukemia cells.Bendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose?Long-term safety experience with bendamustine for injection in a real-world setting.Recent advances in therapy of chronic lymphocytic leukaemia.Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials.Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review.A multicenter, single-arm, Phase II clinical trial of bendamustine monotherapy in patients with chronic lymphocytic leukemia in Japan.Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment.Cardiogenic Shock during First Infusion of Anthracycline Chemotherapy in a Patient with Hodgkin Lymphoma: An Unusual Event.Randomized phase II study of a bendamustine monotherapy schedule for relapsed or refractory low-grade B-cell non-Hodgkin lymphoma or mantle cell lymphoma (RABBIT-14).Bendamustine plus rituximab in chronic lymphocytic leukemia: is there life in the old dog yet?
P2860
Q30243914-AB62E947-7889-4F59-9F7A-472E112BE515Q37725415-DC3B450E-1C96-4F63-827B-1D42618B8A73Q38700745-62C90455-E08F-4C3D-8E03-0F0ADB01F3A5Q38844017-B8535C26-59CA-49F3-8E0F-0C14E146D79EQ38862525-6FF69EEA-93C5-46F9-82DE-7BFF47F4F571Q38979354-242F3319-1568-4ED1-A29A-B60E1BB823A8Q39005626-4605B961-B5E3-4B73-BFD6-8E7DD4135295Q40345871-DF095101-2E71-4F65-8075-10D310F01F5DQ42364241-F02715E7-4D0B-4DF0-A44E-F110135B3671Q50081496-608DA5C2-54C4-4C6A-B348-A5714217127FQ50187344-16D85A87-B499-4E6A-922A-65A31C62C9D3Q55362022-34667039-D8FD-413C-A4C6-126C47A3EE43
P2860
Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an update
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Optimal use of bendamustine in ...... al consensus panel - an update
@en
type
label
Optimal use of bendamustine in ...... al consensus panel - an update
@en
prefLabel
Optimal use of bendamustine in ...... al consensus panel - an update
@en
P2093
P2860
P921
P1433
P1476
Optimal use of bendamustine in ...... al consensus panel - an update
@en
P2093
Bruce D Cheson
Eckhart Weidmann
Gandhi Damaj
Martin Dreyling
Michinori Ogura
Wolfram Brugger
P2860
P304
P356
10.3109/10428194.2015.1099647
P577
2015-11-23T00:00:00Z